SGX Pharmaceuticals Inc., formerly known as Structural GenomiX, Inc., is a biotechnology company focused on the discovery, development and commercialization of cancer therapeutics. The company had licensed exclusive worldwide rights to Troxatyl from Shire BioChem Inc. in July 2004. It was the company's only late stage drug candidate which went through a pivotal phase II/III clinical trial for the third-line treatment of acute myelogenous leukemia (AML), but the company announced its discontinuation on August 28, 2006 due to efficacy insufficiency.

After the failure of its Troxatyl franchise, the company has shifted its focus on its proprietary FAST technology to develop novel drug candidates for cancer and other disease. FAST technology is based upon the use of small fragments of drug-like molecules, known as Fragments of Active Structures (FAST). The company has successfully applied FAST to generate selective small molecule compounds for many proteins (drug targets) that have been implicated in cancers and other diseases. SGX has co-operation with Novartis, Eli Lilly, Cystic Foundation, Roche, Amgen, Biogen Idec, OSI Pharma, NIH and Serono for development of new drug candidates using its FAST technology. However, all these programs are in early discovery stage of development.

SGX Pharma is headquartered in San Diego, California and employs roughly 118 full-time employees. The company was incorporated in Delaware on July 16, 1998 and went public in February 2006.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki